acy-241
Small moleculeexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 7, 2015 (NCT02400242)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Histone deacetylase 1INHIBITOR
HDAC1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- acy-241
- acy-241
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02635061 | Phase 1 | Aug 25, 2016 | Celgene |
| NCT02935790 | Phase 1 | May 1, 2016 | ApoCell, Inc., Celerion, Celgene, Harvard University, INC Research, New York University |
| NCT02551185 | Phase 1 | Dec 22, 2015 | Celgene |
| NCT02400242 | Phase 1 | May 7, 2015 | Celgene, Cornell University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Celgene | For profit | 4 | 4 | 1 | 2015 |
| ApoCell, Inc. | For profit | 1 | 0 | 1 | 2016 |
| Celerion | For profit | 1 | 0 | 1 | 2016 |
| Cornell University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| INC Research | For profit | 1 | 0 | 1 | 2016 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2016 |
7 organizations
Page 1 / 1